Jordan Elm to Selegiline
This is a "connection" page, showing publications Jordan Elm has written about Selegiline.
Connection Strength
0.029
-
Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial. Mov Disord. 2014 Feb; 29(2):263-5.
Score: 0.029
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.